EXCITE PHARMA SERVICES, LLC
Excite Pharma is a leading provider of CDMO and CRO services, specializing in small-scale aseptic manufacturing, analytical chemistry, and drug development. Committed to patient safety and high-quality service, the company serves pharmaceutical and biopharmaceutical clients with a focus on smaller batch projects, offering innovative solutions and comprehensive support from formulation to commercial manufacturing.
Industries
Nr. of Employees
small (1-50)
EXCITE PHARMA SERVICES, LLC
324 NW Capital Dr, Lee's Summit, MO 64086
Services
Contract aseptic filling and sterile manufacturing for clinical and small commercial batches, supporting vial, syringe and ophthalmic formats across multiple fill lines and hand‑fill operations.
Comprehensive analytical support including method development, validation, transfers, identification, assay and impurity testing to support CMC documentation.
In-house batch release testing for drug substances, drug products and excipients per ICH/USP guidance, including chemical, physical and microbiological endpoints.
Analytical method development and validation for APIs, drug products and biological matrices, and transfer of validated methods to client sites or partners.
Design and conduct of stability studies (long-term, accelerated, refrigerated, frozen and photostability) following ICH Q1E to establish shelf-life and storage conditions.
Residual solvent testing by static headspace GC/FID and GC/MS per USP guidance, customized to process-specific solvent profiles.
Contract aseptic filling and sterile manufacturing for clinical and small commercial batches, supporting vial, syringe and ophthalmic formats across multiple fill lines and hand‑fill operations.
Comprehensive analytical support including method development, validation, transfers, identification, assay and impurity testing to support CMC documentation.
In-house batch release testing for drug substances, drug products and excipients per ICH/USP guidance, including chemical, physical and microbiological endpoints.
Analytical method development and validation for APIs, drug products and biological matrices, and transfer of validated methods to client sites or partners.
Design and conduct of stability studies (long-term, accelerated, refrigerated, frozen and photostability) following ICH Q1E to establish shelf-life and storage conditions.
Residual solvent testing by static headspace GC/FID and GC/MS per USP guidance, customized to process-specific solvent profiles.
Expertise Areas
- Aseptic small-batch and clinical manufacturing
- Analytical chemistry and method development
- Stability program design and execution
- Release and batch testing for APIs and drug products
Key Technologies
- HPLC / UPLC
- Gas chromatography (GC) and GC‑MS
- Static headspace GC‑FID
- ICP‑MS (metals analysis)
News & Updates
Excite Pharma will participate in DCAT Week 2025 in New York City, engaging with industry leaders and discussing new capabilities including injectables, nasal gels, and eyedrops.
The Kansas Board of Pharmacy granted Excite Pharma an outsourcing facility license under the 503B designation, marking a significant milestone for the company in 2025.
Partnership with Craftsmen Industries to develop mobile labs, providing custom solutions for pharmaceutical processing and packaging.
Discussion on the challenges and opportunities in pharmaceutical manufacturing post-COVID, including supply chain resilience and local manufacturing initiatives.
Highlighting the need for specialized partners capable of handling small batch aseptic projects, which are often overlooked by larger CDMOs.
Excite Pharma utilizes GC analysis to ensure the quality and purity of pharmaceutical compounds, supporting quality control and regulatory compliance.
Excite Pharma will participate in DCAT Week 2025 in New York City, engaging with industry leaders and discussing new capabilities including injectables, nasal gels, and eyedrops.
The Kansas Board of Pharmacy granted Excite Pharma an outsourcing facility license under the 503B designation, marking a significant milestone for the company in 2025.
Partnership with Craftsmen Industries to develop mobile labs, providing custom solutions for pharmaceutical processing and packaging.
Discussion on the challenges and opportunities in pharmaceutical manufacturing post-COVID, including supply chain resilience and local manufacturing initiatives.
Highlighting the need for specialized partners capable of handling small batch aseptic projects, which are often overlooked by larger CDMOs.
Excite Pharma utilizes GC analysis to ensure the quality and purity of pharmaceutical compounds, supporting quality control and regulatory compliance.